US Stocks

Seagen Inc.

Seagen Inc. is a biotechnology company that develops and markets cancer therapies worldwide, including ADCETRIS and PADCEV. In addition to treatment for advanced breast and urothelial cancer, the company develops several new therapies for various cancer diseases in collaboration with other pharmaceutical companies like Takeda Pharmaceutical and Genmab. Incorporated in 1997, Seagen Inc. is headquartered in Bothell, Washington.